Calliditas Therapeutics AB Analysis
| Analyst Ratings |
|
Average Target Price
|
51.80
|
|
Average Rating
|
4.80
|
|
# Strong Buys
|
4
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
0.27
|
0.00
|
-0.27
|
-100.00%
|
|
2022-12-31
|
-0.34
|
0.00
|
0.34
|
100.00%
|
|
2022-09-30
|
-0.92
|
-0.03
|
0.89
|
96.74%
|
|
2022-06-30
|
-0.74
|
-0.84
|
-0.10
|
-13.51%
|
|
2022-03-31
|
-0.75
|
-0.53
|
0.22
|
29.42%
|
|
2021-12-31
|
-0.66
|
-0.95
|
-0.29
|
-43.94%
|
|
2021-09-30
|
-0.57
|
0.05
|
0.62
|
108.77%
|
|
2021-06-30
|
-0.46
|
-0.76
|
-0.30
|
-65.22%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.40
|
|
2021-12-31
|
-2.26
|
|
2020-12-31
|
-2.06
|
|
2019-12-31
|
-0.15
|
|
2018-12-31
|
-0.47
|